Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer [Phase 1]
This Phase 1 clinical trial from Roswell Park Cancer Institute is evaluating bipolar androgen therapy to restore sensitivity to androgen dep…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer
A Mayo Clinic-sponsored clinical trial aims to determine baseline levels of extracellular vesicles derived from prostate cancer after local …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial is evaluating the safety and efficacy of AGN-INM176 in prostate cancer patients with rising PSA, c…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer [Phase 3]
A Phase 3 clinical trial comparing two boost approaches in radiation therapy for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer [Phase 1]
Phase I trial evaluating Luxdegalutamide (JSB462) in Japanese patients with metastatic prostate cancer (metastatic castration-resistant pros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: FOG-001 in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
FOG-001 is being studied in a Phase 1/2 trial across multiple locally advanced or metastatic solid tumors and is currently recruiting; indic…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain [Phase 4]
Phase 4 clinical trial evaluating laparoscopic TAP block during robotic-assisted radical prostatectomy to reduce postoperative pain in prost…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Multimodal Machine Learning Characterization of Solid Tumors
This ClinicalTrials.gov update describes a multimodal machine learning study to characterize solid tumors, listing prostate cancer, hepatoce…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Low-Count Quantitative SPECT for Men Treated With Radium-223 [NA]
This clinical trial investigates low-count quantitative SPECT imaging in men treated with Radium-223 for prostate cancer. The study is curre…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS) [NA]
A University of Miami-sponsored clinical trial is evaluating metabolic effects and adherence of controlled Mediterranean diet variations in …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: First-Time-in-Human Study of GSK5471713 in Adults With mCRPC [Phase 1, Phase 2]
This clinical trial update notes the first-time-in-human study of GSK5471713 in adults with metastatic castration-resistant prostate cancer,…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer [NA]
This clinical trial update reports a Phase II study evaluating high-dose brachytherapy and low-dose-rate brachytherapy as monotherapy in loc…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer [Phase 2]
A Phase 2 clinical trial update for 18F-DCFPyL PET/CT in high-risk and recurrent prostate cancer, with status currently ACTIVE_NOT_RECRUITIN…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma [Phase 2]
Multi-arm Phase 2 trial evaluating multi-modality therapy for very high-risk localized and low-volume metastatic prostate cancer is currentl…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy [NA]
A clinical trial update shows ongoing recruitment for a study evaluating intermittent fasting in prostate cancer patients receiving androgen…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
A prospective, US-based multi-center validation study to evaluate Proclarix for prostate cancer risk assessment and detection; currently rec…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
Clinical trial update indicating that JANX014 is being studied in Phase 1 for metastatic castration-resistant prostate cancer and is current…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of How People Make Decisions About Prostate Cancer Risk
Memorial Sloan Kettering Cancer Center is recruiting for a study examining how people make decisions about their risk of prostate cancer, in…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Clinical Trial of Approaches to Prostate Cancer Surgery [NA]
This clinical trial update indicates a recruiting study at Weill Medical College of Cornell University exploring surgical approaches for pro…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) [Phase 3]
Phase 3 clinical trial update describing a study of Opevesostat (MK-5684) versus a next-generation hormonal agent in metastatic castration-r…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]
Phase I/II trial evaluating Pembrolizumab in combination with an androgen-receptor inhibitor, with or without 225Ac-J591, for progressive me…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy
A clinical trial comparing robot-assisted laparoscopic radical prostatectomy, conventional laparoscopic radical prostatectomy, and open radi…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation [Phase 3]
A Phase 3 trial evaluating whether adding saruparib to standard radiotherapy and androgen deprivation therapy improves metastasis-free survi…